Skeletal Muscle Loss During Neoadjuvant Therapy for Esophageal Cancer: Is it an Unpreventable Event due to Tumor Progression or Manageable by Intervention?
Crossref DOI link: https://doi.org/10.1245/s10434-024-15937-y
Published Online: 2024-08-03
Published Print: 2024-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Watanabe, Masayuki
Text and Data Mining valid from 2024-08-03
Version of Record valid from 2024-08-03
Article History
Received: 29 February 2024
Accepted: 16 July 2024
First Online: 3 August 2024
Free to read: This content has been made available to all.